Sign in

CIK 0000921114

  • Non-accelerated filer
  • Smaller reporting company

Armata Pharmaceuticals, Inc.

Sign in to watch
Ticker
ARMP
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
Operating
EIN
911549568
Phone
+1 310-665-2928
Business address
5005 MCCONNELL AVE, LOS ANGELES, CA, 90066
Former names
AmpliPhi Biosciences Corp, TARGETED GENETICS CORP /WA/
  1. 4 Shares withheld for taxes President and CEO gave up 7,618 shares (to pay taxes)
  2. 4 Shares withheld for taxes Vice President and CFO gave up 6,170 shares (to pay taxes)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market sale 10% owner sold 399 shares at $0.67 ($267)
  5. 4 Grant or award CFO & VP Finance acquired 35,000 shares (grant or award)
  6. 4 Grant or award Director acquired 10,000 shares (grant or award)
  7. 4 Grant or award President & CEO acquired 50,000 shares (grant or award)
  8. 4 Grant or award Director acquired 10,000 shares (grant or award)
  9. 4 Grant or award Director acquired 10,000 shares (grant or award)
  10. 4 Grant or award Director acquired 10,000 shares (grant or award)
  11. 4 Grant or award Chairman of the Board acquired 15,000 shares (grant or award)
  12. 4 Grant or award Executive Vice President acquired 35,000 shares (grant or award)
  13. 4 Open-market sale 10% owner sold 8,300 shares at $0.91 ($7,550)
  14. 4 Open-market sale 10% owner sold 200 shares at $0.90 ($180)
  15. 4 Open-market sale 10% owner sold 12,900 shares at $0.94 ($12,145)
  16. 4 Open-market sale 10% owner sold 55,200 shares at an average $0.92 ($50,858)
  17. 4 Open-market sale 10% owner sold 2,371 shares at $1.15 ($2,727)
  18. 4 Open-market sale 10% owner sold 42,800 shares at $1.15 ($49,203)
  19. 3 Insider Initial Statement of Ownership
  20. 4 Grant or award CFO & VP Finance acquired 35,000 shares (grant or award)

Page 10 of 14 · 267 filings